Fundraising Foxトレジェムバイオファーマ株式会社
京都 (Kyoto), JP · 4 known investors
Find your way into トレジェムバイオファーマ株式会社
Sign up to see every warm intro you have to トレジェムバイオファーマ株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the トレジェムバイオファーマ株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Toregem Biopharma is a Kyoto University spin-off developing a tooth-regeneration drug based on a humanized anti-USAG-1 antibody that aims to regrow teeth with a single injection. It initially targets patients with congenital tooth agenesis (a rare genetic condition) and ultimately aims to treat tooth loss from decay or periodontal disease.
Founders & leadership
喜ほ
喜早 ほのか (Honoka Kihayashi)代表取締役社長 (Representative Director and President)
髙克
髙橋 克 (Katsu Takahashi)取締役CTO (Director and CTO)
髙宗
髙谷 宗男 (Muneo Takaya)取締役CBO (Director and CBO)
喜ほ
喜早 ほのかCo-founder & CEO (代表取締役社長)
髙克
髙橋 克Co-founder & CTO
髙宗
髙谷 宗男Co-founder & CBO
Investors · 4
Kyoto University Innovation Capitallisted by Kyoto University Innovation CapitalKyoto
How we know: Kyoto University Innovation Capital's portfolio page · Not right? Tell us
Related companies · 1
Companies working in the same space as トレジェムバイオファーマ株式会社.
Frequently asked questions
- What does トレジェムバイオファーマ株式会社 do?
- Toregem Biopharma is a Kyoto University spin-off developing a tooth-regeneration drug based on a humanized anti-USAG-1 antibody that aims to regrow teeth with a single injection. It initially targets patients with congenital tooth agenesis (a rare genetic condition) and ultimately aims to treat tooth loss from decay or periodontal disease.
- Who founded トレジェムバイオファーマ株式会社?
- トレジェムバイオファーマ株式会社 was founded by 喜早 ほのか (Honoka Kihayashi), 髙橋 克 (Katsu Takahashi), 髙谷 宗男 (Muneo Takaya), 喜早 ほのか, 髙橋 克, 髙谷 宗男.
- Who are トレジェムバイオファーマ株式会社's investors?
- トレジェムバイオファーマ株式会社's investors include Astellas Venture Management LLC, Kyoto University Innovation Capital, OSAKA University Venture Capital, TOHOKU University Venture Partners.
- Where is トレジェムバイオファーマ株式会社 headquartered?
- トレジェムバイオファーマ株式会社 is headquartered in 京都 (Kyoto), JP.